News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,702 Results
Type
Article (5048)
Company Profile (5)
Press Release (62649)
Multimedia
Podcasts (98)
Webinars (3)
Section
Business (18681)
Career Advice (184)
Deals (2943)
Drug Delivery (14)
Drug Development (10790)
Employer Resources (26)
FDA (1916)
Job Trends (1921)
News (34222)
Policy (2977)
Tag
Academia (346)
Accelerated approval (8)
Adcomms (5)
Allergies (16)
Alliances (4251)
ALS (36)
Alzheimer's disease (345)
Antibody-drug conjugate (ADC) (34)
Approvals (1910)
Artificial intelligence (41)
Autoimmune disease (23)
Automation (4)
Bankruptcy (22)
Best Places to Work (1625)
BIOSECURE Act (3)
Biosimilars (20)
Biotechnology (5)
Bladder cancer (13)
Brain cancer (8)
Breast cancer (105)
Cancer (766)
Cardiovascular disease (59)
Career advice (145)
CAR-T (41)
CDC (18)
Cell therapy (116)
Cervical cancer (4)
Clinical research (9360)
Collaboration (128)
Company closure (1)
Compensation (66)
Complete response letters (7)
COVID-19 (286)
CRISPR (11)
C-suite (100)
Cystic fibrosis (16)
Data (888)
Depression (24)
Diabetes (55)
Diagnostics (659)
Digital health (4)
Diversity, equity & inclusion (11)
Drug discovery (22)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (59)
Earnings (6466)
Editorial (20)
Employer branding (3)
Employer resources (21)
Events (12075)
Executive appointments (115)
FDA (2288)
Frontotemporal dementia (2)
Funding (166)
Gene editing (18)
Generative AI (3)
Gene therapy (84)
GLP-1 (129)
Government (482)
Grass and pollen (1)
Guidances (44)
Healthcare (1969)
HIV (6)
Huntington's disease (16)
IgA nephropathy (10)
Immunology and inflammation (31)
Immuno-oncology (7)
Indications (15)
Infectious disease (316)
Inflammatory bowel disease (18)
Inflation Reduction Act (2)
Influenza (11)
Intellectual property (23)
Interviews (45)
IPO (1374)
IRA (4)
Job creations (376)
Job search strategy (135)
JPM (14)
Kidney cancer (2)
Labor market (1)
Layoffs (54)
Leadership (3)
Legal (637)
Liver cancer (13)
Longevity (2)
Lung cancer (60)
Lymphoma (91)
Machine learning (2)
Management (5)
Manufacturing (73)
MASH (27)
Medical device (1236)
Medtech (1239)
Mergers & acquisitions (1654)
Metabolic disorders (188)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (57)
Neuropsychiatric disorders (17)
Neuroscience (552)
NextGen: Class of 2026 (752)
Non-profit (557)
Obesity (106)
Opinion (23)
Ovarian cancer (22)
Pain (21)
Pancreatic cancer (32)
Parkinson's disease (41)
Partnered (2)
Patents (58)
Patient recruitment (61)
Peanut (7)
People (7383)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase 1 (2683)
Phase 2 (4065)
Phase 3 (3425)
Pipeline (617)
Policy (83)
Postmarket research (340)
Preclinical (1000)
Prostate cancer (111)
Psychedelics (26)
Radiopharmaceuticals (51)
Rare diseases (109)
Real estate (478)
Recruiting (10)
Regulatory (2429)
Reports (2)
Research institute (287)
Resumes & cover letters (30)
Rett syndrome (11)
RNA editing (1)
RSV (12)
Schizophrenia (46)
Series A (31)
Series B (13)
Sickle cell disease (7)
Special edition (10)
Spinal muscular atrophy (10)
Sponsored (4)
Startups (375)
Stomach cancer (1)
Supply chain (3)
Tariffs (11)
The Weekly (97)
Vaccines (157)
Venture capital (9)
Weight loss (53)
Women's health (5)
Date
Last 7 days (63)
Last 30 days (227)
Last 365 days (3256)
2026 (300)
2025 (3271)
2024 (3830)
2023 (4686)
2022 (5411)
2021 (6276)
2020 (5726)
2019 (5134)
2018 (3808)
2017 (3174)
2016 (2894)
2015 (4020)
2014 (2754)
2013 (1757)
2012 (1909)
2011 (2000)
2010 (1754)
Location
Africa (88)
Alabama (2)
Alaska (3)
Arizona (12)
Arkansas (1)
Asia (2877)
Australia (855)
California (1169)
Canada (383)
China (85)
Colorado (28)
Connecticut (49)
Delaware (72)
Europe (9346)
Florida (184)
Georgia (18)
Idaho (5)
Illinois (70)
India (4)
Indiana (77)
Iowa (11)
Japan (57)
Kansas (6)
Kentucky (8)
Louisiana (3)
Maine (5)
Maryland (175)
Massachusetts (966)
Michigan (11)
Minnesota (84)
Missouri (14)
Montana (4)
Nebraska (1)
Nevada (5)
New Hampshire (10)
New Jersey (359)
New Mexico (5)
New York (363)
North Carolina (89)
North Dakota (2)
Northern California (610)
Ohio (22)
Oklahoma (4)
Oregon (3)
Pennsylvania (253)
Puerto Rico (10)
Rhode Island (9)
South America (98)
South Carolina (1)
Southern California (392)
Tennessee (14)
Texas (125)
United States (4242)
Utah (9)
Virginia (19)
Washington D.C. (4)
Washington State (65)
Wisconsin (16)
67,702 Results for "erasmus mc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
February 5, 2026
·
4 min read
Press Releases
TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma
January 6, 2026
·
5 min read
Press Releases
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
February 1, 2026
·
5 min read
Press Releases
Jyong Biotech Expands Regional Partnerships, Signs MOU with a Vietnam Pharmaceutical Distributor for MCS‑2 Market Entry
December 4, 2025
·
4 min read
Press Releases
Jyong Biotech Announces Completion of Primary Endpoint Statistical Analysis for Phase II Clinical Trial of MCS-8 With Positive Outcomes
November 21, 2025
·
5 min read
Press Releases
First procedure in Netherlands with NaoTrac surgical navigation robot is performed at Erasmus MC Rotterdam
July 17, 2024
·
2 min read
Press Releases
TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode’s Phase 1 trial
December 12, 2025
·
6 min read
Press Releases
Former Pfizer Chief Scientific Officer joins MC Sciences as Independent Chairman
August 13, 2025
·
5 min read
Press Releases
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
October 15, 2025
·
6 min read
Drug Development
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
AIM ImmunoTech Inc. today announced that it has received authorization from the Erasmus Medical Center (“Erasmus MC”) Ethics Committee to open a European site for the ongoing Phase 2 study (“AMP-270”) of Ampligen as a therapy for locally advanced pancreatic cancer.
January 24, 2024
·
2 min read
1 of 6,771
Next
